Detalles de la búsqueda
1.
Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F]SiTATE.
Front Oncol
; 13: 992316, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36793617
2.
Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT.
Cancer Imaging
; 18(1): 34, 2018 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30236163
3.
Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma.
PLoS One
; 13(10): e0204930, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30281669
4.
18F-FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanoma.
Cancer Imaging
; 18(1): 2, 2018 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29347968
5.
αvß3-Integrin-Targeted Magnetic Resonance Imaging for the Assessment of Early Antiangiogenic Therapy Effects in Orthotopic Breast Cancer Xenografts.
Invest Radiol
; 51(11): 746-755, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27082316
6.
68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer.
PLoS One
; 11(12): e0168248, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27992512
7.
Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation.
PLoS One
; 10(2): e0115543, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25668193
Resultados
1 -
7
de 7
1
Próxima >
>>